These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28281515)

  • 1. [Clinical and metabolic features of nonalcoholic fatty liver disease in men and women].
    Krivosheev AB; Kuimov AD; Bogoryanova PA; Kondratova MA; Kupriyanova LY; Popov KV; Tuguleva TA
    Ter Arkh; 2017; 89(2):45-51. PubMed ID: 28281515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NON-ALCOHOLIC FATTY LIVER DISEASE IN ELDERLY.
    Krivosheev AB; Kuimov AD; Popov KV; Kondratova MA; Tuguleva TA; BoGoryanova PA
    Eksp Klin Gastroenterol; 2016; (9):27-31. PubMed ID: 29889391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic manifestations of women with polycystic ovary syndrome.
    Chen MJ; Ho HN
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism].
    Zhaldak DA; Melekhovets OK; Orlovskyi VF
    Ter Arkh; 2017; 89(10):62-65. PubMed ID: 29171472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
    Ahmed MH; Ali A
    Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFFECT THE CARDIOMETABOLIC RISK FACTORS ON VASCULAR AGING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE CONCOMITANT WITH SUBCLINICAL HYPOTHYROIDISM.
    Kolesnikova E; Potapenko A
    Georgian Med News; 2017 Sep; (270):69-75. PubMed ID: 28972487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concise review of non-alcoholic fatty liver disease.
    Than NN; Newsome PN
    Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
    Miele L; Targher G
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.
    Xu X; Lu L; Dong Q; Li X; Zhang N; Xin Y; Xuan S
    Lipids Health Dis; 2015 Dec; 14():158. PubMed ID: 26631018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.
    Gaharwar R; Trikha S; Margekar SL; Jatav OP; Ganga PD
    J Assoc Physicians India; 2015 Jan; 63(1):12-6. PubMed ID: 26591121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
    Pacana T; Fuchs M
    Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.